Skip To Main Content

This website is intended exclusively for Registered Medical Practitioners (RMP’s) registered with the National Medical Commission (NMC) and their respective State Medical Councils/statutory authorities in India.

Campus
Campus

Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy to match daily life needs of people with T2DM

Here's a podcast starring Pr. Stewart Harris and Pr. Othmar Moser, discussing the importance of simple dosing and titration, flexible to match daily life needs

Related articles
Safe, Flexible and Proven: Gen 2.0 Basal Insulin Therapy Across Diverse T2D Populations

Safe, Flexible and Proven: Gen 2.0 Basal Insulin Therapy Across Diverse T2D Populations

Join Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across diverse Type 2 diabetes populations, including older adults and those with renal impairment.

Learn more
Soli-SWITCH study

Soli-SWITCH study

Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes

Learn more
Soli-CGM study

Soli-CGM study

Effect of iGlarLixi on continuous glucose monitoring measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes

Learn more
MAT-IN-2601087-1.0/09.2026